All In Biotech

Free tool

FAERS Monitor: Atralin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022070 or its brand name (Atralin, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

6,575

Serious

4,123

63% of reports

Hospitalization

1,418

Death reported

851

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use879
  • drug ineffective733
  • pain490
  • product use in unapproved indication484
  • vomiting452
  • paraesthesia373
  • abdominal pain upper369
  • rash364
  • nausea355
  • diarrhoea348
  • headache338
  • maternal exposure during pregnancy338
  • taste disorder332
  • drug intolerance327
  • gastrooesophageal reflux disease327

Reports by year received

View as table
YearReports
200437
200531
200624
200739
2008115
200972
201078
201191
2012153
2013101
2014155
2015233
2016354
2017350
2018460
2019353
2020376
2021428
2022512
2023568
2024674
2025809
2026562

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,584 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
taste disorderSignal33253.247.916,692
gastrooesophageal reflux diseaseSignal32713.011.73,623
maternal exposure during pregnancySignal33812.211.03,457
drug intoleranceSignal32710.99.82,922
paraesthesiaSignal3737.66.92,142
product use in unapproved indicationSignal4846.35.72,154
abdominal pain upperSignal3695.75.21,452
off label useSignal8793.23.01,395
vomitingSignal4523.12.8646
rashSignal3642.72.4387
painSignal4902.62.3475
drug ineffective7331.81.7266
diarrhoea3481.71.6109
headache3381.71.6105
nausea3551.41.348

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.